9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma	Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, renal pelvis/ureter urothelial carcinoma, transitional cell carcinoma, urothelial carcinoma	Recruiting	Phase 2	2025-03-21		NCT06823427

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Mabwell (Shanghai) Bioscience Co., Ltd.	23

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Hunan Tumor Hospital	Changsha	China	1
Nanjing Drum Tower Hospital	Nanjing	China	22

Clinical trials